FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...
Crohn’s Disease Pipeline Insights, FDA Approvals, Drugs, Companies Report | DelveInsight
The leading Crohn's Disease companies such as Janssen, RedHill Biopharma, Amgen, Pfizer, Hoffmann-La Roche, Gilead Sciences, Eli Lilly and Company, Celgene, AstraZeneca, Abbvie, Mesoblast, Alfasigma, ...
Managing the twin challenges of hypothyroidism and anaemia in India
Hypothyroidism affects nearly 1 in 10 adults in India. 41.8% people living with hypothyroidism are also diagnosed with ...
Healio22h
Chronic HBV treatment with xalnesiran plus immunomodulator confers highest HBsAg loss
Treatment with xalnesiran, a small interfering RNA molecule, plus an immunomodulator resulted in hepatitis B surface antigen loss among adults with chronic HBV infection, according to a study ...
Johns Hopkins Medicine17h
Heart Failure
Chronic heart failure develops over time from medical conditions such as long-term hypertension (high blood pressure) or coronary artery disease. Many people use the terms heart failure and congestive ...